Atlas Venture Life Science Advisors, LLC Kymera Therapeutics, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $606 Million
- Q4 2024
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 4,896,462 shares of KYMR stock, worth $163 Million. This represents 32.49% of its overall portfolio holdings.
Number of Shares
4,896,462
Previous 4,896,462
-0.0%
Holding current value
$163 Million
Previous $232 Million
15.0%
% of portfolio
32.49%
Previous 28.59%
Shares
6 transactions
Others Institutions Holding KYMR
# of Institutions
187Shares Held
60.3MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$229 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$199 Million2.67% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$172 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$171 Million3.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$163 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.82B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...